StemInov
French tech company | Builders Republic
About
Clinical-stage biotech developing a cell therapy made from mesenchymal stem cells extracted from umbilical-cord tissue — its lead product WhartSep targets severe inflammatory conditions such as septic shock and acute respiratory distress syndrome, which lack specific treatments, spun off from Nancy university hospital.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2019
- City
- VANDŒUVRE-LES-NANCY
- Region
- Grand Est
- Tracked rounds
- 1
- Amount raised
- 11 M€ raised since 2020
Funding rounds
- Seed — 2025